from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0481c/-

LFCtreatmentdescriptionclass of inhibitor

-0.168

Amikacinug/mL Amikacintranslation

-0.015

Cap5-10ug/mL Capreomycintranslation

0.215

Rox10-50 ug/mL Roxithromycintranslation

-0.355

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.785

Rif0.2-5ug/mL Rifampicintranscription

0.510

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.908

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.809

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.360

CPZ10-50 ug/mL Chlorpromazinerespiration

0.088

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.477

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.307

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.420

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.366

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.471

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.726

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.145

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.280

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.187

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.304

Nigericin50 uM Nigericinrespiration

-0.267

TRC10-150 ug/mL Triclosanrespiration

-1.188

TRZ10-25 ug/mL Thioridazinerespiration

-0.829

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.792

menadione6-10 ug/mL Menadionerespiration

0.768

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.379

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.702

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.084

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.230

NRP_1Non-replicating persistence stage 1dosRassociated

0.116

Amp0.2mg/mL AmpicillincellWall

-0.255

Cephalexin20-100 ug/mL CephalexincellWall

-0.064

Cerulenin0.32-5 ug/mL CerulenincellWall

0.555

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.203

EMB10-20 ug/mL EthambutolcellWall

0.414

Eta12-40 ug/mL EthionamidecellWall

0.544

INH0.2-0.4 ug/mL IsoniazidcellWall

0.774

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.616

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.094

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.630

BZA0.12 mg/mL BenzamidearomaticAmides

0.564

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.507

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.563

H2O24 mM hydrogen peroxideDNAdamaging

0.264

Levo10 ug/mL LevofloxacinDNAdamaging

0.508

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.582

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.016

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.303

UVUV-irradiationDNAdamaging

-0.536

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.456

Antimycin12.5-50 ug/mL Antimycin A?

-0.991

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.636

PA_110-50 ug/mL Antitubercular compound PA-1?

0.467

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.025

PA8240.2-2 ug/mL PA-824?

-0.540

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.001

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.057

Verapamil50 uM Verapamil?

-1.296

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.293

methoxatin10-20 ug/mL Methoxatin?